CoChat

Serum C‐peptide levels and breast cancer risk: Results from the European prospective investigation into cancer and nutrition (EPIC)

Open access
Verheus, Martijn, Peeters, Petra H.M., Rinaldi, Sabina, Dossus, Laure, Biessy, Carine, Olsen, Anja, Tjønneland, Anne, Overvad, Kim, Jeppesen, Majbritt, Clavel‐Chapelon, Françoise, Téhard, Bertrand, Nagel, Gabriele, Linseisen, Jakob, Boeing, Heiner, Lahmann, Petra H., Arvaniti, Athina, Psaltopoulou, Theodora, Trichopoulou, Antonia, Palli, Domenico, Tumino, Rosario, Panico, Salvatore, Sacerdote, Carlotta, Sieri, Sabina, van Gils, Carla H., Bueno‐de‐Mesquita, Bas H., González, Carlos A., Ardanaz, Eva, Larranaga, Nera, Garcia, Carmen Martinez, Navarro, Carmen, Quirós, J. Ramón, Key, Tim, Allen, Naomi, Bingham, Sheila, Khaw, Kay‐Tee, Slimani, Nadia, Riboli, Elio, Kaaks, Rudolf · 2006 · International Journal of Cancer
Cited by 102

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

It has been hypothesized that chronic hyperinsulinemia, a major metabolic consequence of physical inactivity and excess weight, might increase breast cancer risk by direct effects on breast tissue or indirectly by increasing bioavailable levels of testosterone and estradiol. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), we measured serum levels of C‐peptide—a marker for pancreatic insulin secretion—in a total of 1,141 incident cases of breast cancer and 2,204 matched control subjects. Additional measurements were made of serum sex hormone binding globulin (SHBG) and sex steroids. Conditional logistic regression models were used to estimate breast cancer risk for different levels of C‐peptide. C‐peptide was inversely correlated with SHBG and hence directly correlated with free testosterone among both pre and postmenopausal women. C‐peptide and free estradiol also correlated positively, but only among postmenopausal women. Elevated serum C‐peptide levels were associated with a nonsignificant reduced risk of breast cancer diagnosed up to the age of 50 years [odds ratio (OR) = 0.70, (95% confidence interval (CI), 0.39–1.24); ptrend = 0.05]. By contrast, higher levels of C‐peptide were associated with an increase of breast cancer risk among women above 60 years of age, however only among those women who had provided a blood sample under nonfasting conditions [OR = 2.03, (95% CI, 1.20–3.43); ptrend = 0.01]. Our results do not support the hypothesis that chronic hyperinsulinemia generally increases breast cancer risk, independently of age. Nevertheless, among older, postmenopausal women, hyperinsulinemia might contribute to increasing breast cancer risk. © 2006 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.21861

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 102

Metadata

Authors
Verheus, M., Peeters, P. H. M., Rinaldi, S., Dossus, L., Biessy, C., Olsen, A., Tjønneland, A., Overvad, K., Jeppesen, M., Clavel‐Chapelon, F., Téhard, B., Nagel, G., Linseisen, J., Boeing, H., Lahmann, P. H., Arvaniti, A., Psaltopoulou, T., Trichopoulou, A., Palli, D., Tumino, R., Panico, S., Sacerdote, C., Sieri, S., van Gils, C. H., Bueno‐de‐Mesquita, B. H., González, C. A., Ardanaz, E., Larranaga, N., Garcia, C. M., Navarro, C., Quirós, J. R., Key, T., Allen, N., Bingham, S., Khaw, K., Slimani, N., Riboli, E., & Kaaks, R.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2006-05-08
Volume
119
Issue
3
Pages
659-667
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2098390983
Cited by
102
References
4
FWCI
4.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.